Buy One Get One free -Llimited Time Offer X
Glimtaz, a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of Diabetes. Other than this, Glimtaz has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Glimtaz. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Some other side effects of Glimtaz have been listed ahead. Such side effects of Glimtaz normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Glimtaz's effect is Moderate during pregnancy and Moderate for lactating mothers. In addition, Glimtaz's effects on the liver, heart and kidney are discussed below in the Glimtaz related warnings section.
Glimtaz is not recommended if you suffer from certain medical conditions as it can have adverse effects. Heart Disease, Liver Disease, Kidney Disease are examples of such conditions. Some other conditions that can be affected by Glimtaz are listed in the contraindications section below.
Drug reaction of Glimtaz with other medicines has been reported. A complete list of these interactions is given below.
In addition to the above precautions for Glimtaz, it is important to know that it is safe while driving, and is habit-forming.
Glimtaz is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Glimtaz is used -
Moderate
Mild
Is the use of Glimtaz safe for pregnant women?
Glimtaz may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Glimtaz again without your doctor's advice.
Is the use of Glimtaz safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Glimtaz. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Glimtaz on the Kidneys?
Glimtaz rarely harms the kidneys.
What is the effect of Glimtaz on the Liver?
There may be an adverse effect on the liver after taking Glimtaz. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Glimtaz on the Heart?
Glimtaz may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
Glimtaz should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Glimtaz unless your doctor advises you to do so -
Is this Glimtaz habit forming or addictive?
Glimtaz is not addictive in nature.
Interaction between Food and Glimtaz
Due to a lack of research, nothing can be said about the consequences of taking Glimtaz together with food.
Interaction between Alcohol and Glimtaz
Chances of side effects of drinking alcohol while taking Glimtaz are low. If you feel any adverse effects, please seek medical advice as soon as possible.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Actos (pioglitazone hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 276-277
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1032-1033